These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11287099)

  • 1. ATP stimulated cyclic AMP formation in bovine chromaffin cells is enhanced by neuropeptide Y.
    Zhang P; Zheng J; Bradley ME; Hexum TD
    Peptides; 2001 Mar; 22(3):439-44. PubMed ID: 11287099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells.
    Zheng J; Zhang P; Toews M; Hexum TD
    Biochem Biophys Res Commun; 1997 Oct; 239(1):287-90. PubMed ID: 9345312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation.
    Drakulich DA; Walls AM; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 2003 Nov; 307(2):559-65. PubMed ID: 12970392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation.
    Zheng J; Zhou G; Hexum TD
    Life Sci; 2000 Jun; 67(6):617-25. PubMed ID: 12659167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide YY1 receptors-mediated increase in intracellular Ca2+ concentration via phospholipase C-dependent pathway in porcine aortic smooth muscle cells.
    Shigeri Y; Nakajima S; Fujimoto M
    J Biochem; 1995 Sep; 118(3):515-20. PubMed ID: 8690710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y Y2 receptor signalling mechanisms in the human glioblastoma cell line LN319.
    Grouzmann E; Meyer C; Bürki E; Brunner H
    Peptides; 2001 Mar; 22(3):379-86. PubMed ID: 11287092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betagamma subunits mediate the NPY enhancement of ATP-stimulated inositol phosphate formation.
    Li X; Ikezu T; Hexum TD
    Peptides; 2004 Feb; 25(2):267-74. PubMed ID: 15063008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J; Li W; Toews ML; Hexum TD
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an NPY-Y1 receptor subtype in bovine chromaffin cells.
    Zhang P; Zheng J; Vorce RL; Hexum TD
    Regul Pept; 2000 Feb; 87(1-3):9-13. PubMed ID: 10710282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2-Arachidonoylglycerol.
    Signorello MG; Leoncini G
    J Cell Biochem; 2016 May; 117(5):1240-9. PubMed ID: 26460717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of nicotinic responses of bovine adrenal chromaffin cells by the protein kinase C inhibitor, Ro 31-8220.
    Marley PD; Thomson KA
    Br J Pharmacol; 1996 Sep; 119(2):416-22. PubMed ID: 8886429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NPY1-36 and PYY1-36 activate cardiac fibroblasts: an effect enhanced by genetic hypertension and inhibition of dipeptidyl peptidase 4.
    Zhu X; Gillespie DG; Jackson EK
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1528-42. PubMed ID: 26371160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis.
    Robidoux J; Simoneau L; St-Pierre S; Ech-Chadli H; Lafond J
    Am J Physiol; 1998 Mar; 274(3):E502-9. PubMed ID: 9530134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
    Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
    J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process.
    Zheng J; Zhang P; Hexum TD
    Mol Pharmacol; 1997 Dec; 52(6):1027-33. PubMed ID: 9415712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel phospholipase C- and cAMP-independent positive inotropic mechanism via a P2 purinoceptor.
    Podrasky E; Xu D; Liang BT
    Am J Physiol; 1997 Nov; 273(5):H2380-7. PubMed ID: 9374775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of G protein and phospholipase C-coupled agonist binding to the Y1 neuropeptide Y receptor in rat brain: sensitivity to G protein activators and inhibitors and to inhibitors of phospholipase C.
    Parker SL; Parker MS; Sweatman T; Crowley WR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):382-91. PubMed ID: 9655883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
    Nörenberg W; Bek M; Limberger N; Takeda K; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):337-47. PubMed ID: 7543184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The negative inotropic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Piper HM; Millar BC; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):333-7. PubMed ID: 2554154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiadrenergic effect of neuropeptide Y on the ventricular cardiomyocyte.
    Millar BC; Piper HM; McDermott BJ
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):426-9. PubMed ID: 2854210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.